Toragen, Inc. Announces Chief Medical Officer to Drive the Company’s Clinical Development
October 7, 2022

Toragen, Inc. Announces Raising $5.4M in a Series Seed Round
September 30, 2022

Toragen, Inc. Announces the Appointment of Board of Directors and Senior Staff
August 15, 2022

Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. as CEO
February 09, 2022


Events & Presentations

Zoom Meeting Investor Presentation
Please contact Cheryl Collett to obtain the password.


Investor FAQ

Company history and general

Q: When and where was Toragen incorporated?
A: Toragen was incorporated in 2016 in Delaware
Q: Where is Toragen headquartered?
A: Toragen’s headquarters and mailing address are at Biolabs, San Diego at 10210 Campus Point Dr., #150, San Diego, CA 92121
Q: What is Toragen developing?
A: Toragen is currently developing therapeutics for the treatment of HPV-induced cancers. More information can be found here.

Investing and stock

Q: How do I purchase shares of Toragen stock?
A: Toragen’s stock is currently private and not available for purchase through a stock exchange. If you wish to invest in Toragen please contact
Q: Can Toragen offer investment advice regarding my investment?
A: Unfortunately, Toragen cannot offer investment advice with regard to your current or future investment. Please contact your tax professional or financial advisor.
Q: Can I get a copy of my stock certificate representing my investment in Toragen, Inc.?
A: Please contact should you need access to your documents.
Q: How do I receive quarterly or annual updates on Toragen, Inc.?
A: Updates are typically sent quarterly via email. Please inform us immediately if you are not receiving these updates or would like to change your email address.


Accounting and Accounts Payable:
Investor Relations:

%d bloggers like this: